Daniela Begolo

Managing Director

2023 - Current

Principal

2022 - 2022

Senior Associate

2020 - 2021

Associate

2019 - 2020

Analyst

2018 - 2019

Part of the Healthcare team of M Ventures, corporate VC of Merck KGaA. Comprehensive due diligence to support strategic private equity investments in early stage biotech companies, in particular in oncology and immunology. Support to the team, in portfolio company strategy analysis.

Postoctoral Researcher

2017 - 2017

Mode of action analysis of a small molecules compound series in the parasite T. brucei Independent development of research project; biochemistry, molecular biology and cell biology techniques; student supervision and mentorship

Early Stage Researcher, Marie Skłodowska-Curie Actions fellow

2013 - 2017

Development of molecular tools for drug target identification in T. brucei Autonomous development of research project; molecular biology, cell biology, genomics, metabolomics; frequent work-related traveling; student supervision